Ekso Bionics Holding (EKSO) 0.7900 $EKSO
Ekso Bionics(TM) to Present at AHIMA's Annual Convention & Exhibit: Leading the Way to Health Intelligence
GlobeNewswire - Thu Sep 25, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, is a keynote speaker at the San Diego Convention Center Exhibit Hall for the American Health Information Management Association's 86 Convention on Monday September 29, 8:50 am PDT. Health information management and technology professionals, government leaders and healthcare executives will gather in San Diego to address how health information management is transforming the healthcare industry. Mr. Harding's session titled, "Leading the Way: Life Changing Innovation" will feature a live demonstration of Ekso Bionic's robotic exoskeleton technology showing the benefit of technology merging with healthcare.
Kessler Foundation Study Finds Ekso(TM) Bionic Suit is Safe and Effective for Gait Training Stroke Patients in Inpatient Rehabilitation Setting
GlobeNewswire - Thu Sep 18, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced new findings from a feasibility study conducted by Kessler Foundation, which reported that eight stroke patients who were prescribed gait training during inpatient rehabilitation training, safely increased their cadence (steps per minute) after six weeks of rehabilitation with the assistance of the Ekso(TM) GT robotic exoskeleton. The patients were gait trained using the Ekso device for 25% of their total physical therapy time. Average cadence with the Ekso robotic exoskeleton was 17.1 at initial session, which increased to 27.67 by the final session. The study "Gait Training of Stroke Patients using a Robotic Exoskeleton during Inpatient Rehabilitation: Feasibility Study" was presented by Karen J. Nolan, PhD, research scientist at Kessler Foundation during the International Workshop of Wearable Robotics in Baiona, Pontevedra, Spain from September 14-19.
Ekso(TM) Clear Leader in Exoskeleton Comparison Study Presented at The International Workshop on Wearable Robotics
GlobeNewswire - Wed Sep 17, 8:28AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Bergmannstrost Center in Halle, Germany, a leader in rehabilitation research, presented data today at The International Workshop on Wearable Robotics, WeRob2014 in Baiona, Spain showing the benefits of the Ekso(TM) robotic suit compared to ReWalk and Cyberdyne. The presentation followed recent publication of the article "Comparison of Therapy with the Exoskeletons ReWalk, Ekso and HAL" by Dr. Jane Nitschke and Dr. Klaus Rohl, which was published in German in the Journal Orthopadietechnik.
Ekso Bionics(TM) to Demonstrate Robotic Exoskeleton Technology at Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo
GlobeNewswire - Fri Aug 29, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Ekso Bionics will be demonstrating their technology at the Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo August 31 thru September 3 at Hyatt Regency at the Arch, St. Louis Missouri. With close to 80 suits being used on over 60 centers internationally, Ekso Bionics is the most widely used robotic exoskeleton rehabilitation device worldwide.
Ekso Bionics(TM) to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 4:00PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern time at The InterContinental Hotel in Boston, MA. A live demonstration of their bionic exoskeleton technology will also be provided. Interested parties can access a live audio webcast on the Ekso Bionics website or by directly registering with Canaccord. An archived presentation will be available on the web site for 30 days.
Ekso Bionics Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:44PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter ended June 30, 2014, as well as recent highlights.
Ekso Bionics(TM) CEO Nathan Harding Interview on CNBC's Closing Bell Rescheduled
GlobeNewswire - Mon Aug 04, 12:23PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that, due to a breaking announcement from President Obama, CEO Nathan Harding's interview will be rescheduled to a later date.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Today, on CNBC'S Closing Bell
GlobeNewswire - Mon Aug 04, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Monday August 4th on CNBC's Closing Bell
GlobeNewswire - Fri Aug 01, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.
Ekso Bionics to Provide Corporate Update and Host Second Quarter Call on Thursday, August 7, 2014
GlobeNewswire - Thu Jul 31, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss quarterly results for its second quarter 2014 and provide a general business update on Thursday, August 7, 2014 at 4:30pm ET.
Ekso Bionics(TM) Named 'Leading Robotics Company' by Healthcare Robotics: 2014
GlobeNewswire - Thu Jul 24, 6:01AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was featured in Robotics Business Review Industry Special Report 'Healthcare Robotics: 2014' that describes medical robotic exoskeletons as "probably the most exciting segment of the entire medical robotics market right now."
Kessler Foundation Presents Data on Ekso(TM) at World Congress of Biomechanics
GlobeNewswire - Tue Jul 22, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Kessler Foundation, a global leader in rehabilitation research, has presented preliminary data at World Congress of Biomechanics held in Boston, MA, July 5-10, showing that spinal cord injury (SCI) motor incomplete and complete users were able to actively increase step swing time, stride length and hip extension after walking with an Ekso(TM) robotic exoskeleton. Most notably, muscle activation per gait cycle increased with training and became more similar to able-bodied walking.
Ekso Bionics(TM) Completes Training at Switzerland's Largest Rehabilitation Center
Thomson Reuters ONE - Tue Jul 15, 6:00AM CDT
RICHMOND, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that SPC Nottwil has finished training their team of physiotherapists with their Ekso GT(TM) robotic exoskeleton for neurorehabilitation and started to book patients to learn how to walk again. SPC Nottwil is the largest of Switzerland's four special clinics for para and tetraplegics; they consistently treat over 70% of all people with spinal paralysis in Switzerland and are fully occupied all year round. They have joined an esteemed group of European centers with an Ekso(TM) robotic exoskeleton including the top rated Insitut Guttman in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark, now part of Glostrup Hospital. Robotic exoskeletons have been gaining adoption in the neurorehabilitation community as a strong and growing body of evidence shows they are able to engage the principles of neuroplasticity for improved patient outcomes.
Emerging Market Companies and Investor Updates Provided by BrokerBank Securities, Inc.
PR Newswire - Thu Jun 26, 6:00AM CDT
NYBD Holding, Inc. (OTCBB: NYBD) has filed for a name change and it has been accepted. The company will now be trading under (AQUA), will be named Pleasant Kids, Inc. and the company is expecting the name and symbol change to take affect within the next few business days.
Ekso Bionics(TM) to Present at the 9th Annual JMP Securities Healthcare Conference
GlobeNewswire - Wed Jun 18, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder will present a corporate update at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 2:30 p.m. EDT in New York City. A live demonstration of their bionic exoskeleton technology will also be provided.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live Today on Fox Business Network's "Opening Bell with Maria Bartiromo"
GlobeNewswire - Fri Jun 13, 5:30AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Maria Bartiromo on Fox Business Network's Opening Bell with Maria Bartiromo. Any interested parties may tune in and listen live.
Ekso Bionics(TM) Announces Launch of Ekso(TM) Labs
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that co-founder Russ Angold was named president of the company's division focused on technology development and future applications, formally named Ekso Labs. Russ will oversee and build out the division that is responsible for developing intellectual property through engineering contracts and research grants from government organizations and industrial partners, including the Department of Defense (DOD). Ekso Bionics has a long history of engineering services work creating an important intellectual property portfolio dating back to the company's inception in 2005.
Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Wed Mar 26, 7:45AM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
Ekso Bionics(TM) to Present at AHIMA's Annual Convention & Exhibit: Leading the Way to Health Intelligence
GlobeNewswire - Thu Sep 25, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, is a keynote speaker at the San Diego Convention Center Exhibit Hall for the American Health Information Management Association's 86 Convention on Monday September 29, 8:50 am PDT. Health information management and technology professionals, government leaders and healthcare executives will gather in San Diego to address how health information management is transforming the healthcare industry. Mr. Harding's session titled, "Leading the Way: Life Changing Innovation" will feature a live demonstration of Ekso Bionic's robotic exoskeleton technology showing the benefit of technology merging with healthcare.
Kessler Foundation Study Finds Ekso(TM) Bionic Suit is Safe and Effective for Gait Training Stroke Patients in Inpatient Rehabilitation Setting
GlobeNewswire - Thu Sep 18, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced new findings from a feasibility study conducted by Kessler Foundation, which reported that eight stroke patients who were prescribed gait training during inpatient rehabilitation training, safely increased their cadence (steps per minute) after six weeks of rehabilitation with the assistance of the Ekso(TM) GT robotic exoskeleton. The patients were gait trained using the Ekso device for 25% of their total physical therapy time. Average cadence with the Ekso robotic exoskeleton was 17.1 at initial session, which increased to 27.67 by the final session. The study "Gait Training of Stroke Patients using a Robotic Exoskeleton during Inpatient Rehabilitation: Feasibility Study" was presented by Karen J. Nolan, PhD, research scientist at Kessler Foundation during the International Workshop of Wearable Robotics in Baiona, Pontevedra, Spain from September 14-19.
Ekso(TM) Clear Leader in Exoskeleton Comparison Study Presented at The International Workshop on Wearable Robotics
GlobeNewswire - Wed Sep 17, 8:28AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Bergmannstrost Center in Halle, Germany, a leader in rehabilitation research, presented data today at The International Workshop on Wearable Robotics, WeRob2014 in Baiona, Spain showing the benefits of the Ekso(TM) robotic suit compared to ReWalk and Cyberdyne. The presentation followed recent publication of the article "Comparison of Therapy with the Exoskeletons ReWalk, Ekso and HAL" by Dr. Jane Nitschke and Dr. Klaus Rohl, which was published in German in the Journal Orthopadietechnik.
Ekso Bionics(TM) to Demonstrate Robotic Exoskeleton Technology at Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo
GlobeNewswire - Fri Aug 29, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Ekso Bionics will be demonstrating their technology at the Academy of Spinal Cord Injury Professionals 2014 Educational Conference and Expo August 31 thru September 3 at Hyatt Regency at the Arch, St. Louis Missouri. With close to 80 suits being used on over 60 centers internationally, Ekso Bionics is the most widely used robotic exoskeleton rehabilitation device worldwide.
Ekso Bionics(TM) to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 4:00PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 5:00 p.m. Eastern time at The InterContinental Hotel in Boston, MA. A live demonstration of their bionic exoskeleton technology will also be provided. Interested parties can access a live audio webcast on the Ekso Bionics website or by directly registering with Canaccord. An archived presentation will be available on the web site for 30 days.
Ekso Bionics Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:44PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter ended June 30, 2014, as well as recent highlights.
Ekso Bionics(TM) CEO Nathan Harding Interview on CNBC's Closing Bell Rescheduled
GlobeNewswire - Mon Aug 04, 12:23PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that, due to a breaking announcement from President Obama, CEO Nathan Harding's interview will be rescheduled to a later date.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Today, on CNBC'S Closing Bell
GlobeNewswire - Mon Aug 04, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live, Monday August 4th on CNBC's Closing Bell
GlobeNewswire - Fri Aug 01, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton company, today announced that CEO Nathan Harding will be interviewed live by host Kelly Evans on CNBC Network's Closing Bell. Any interested parties may tune in and listen live.
Ekso Bionics to Provide Corporate Update and Host Second Quarter Call on Thursday, August 7, 2014
GlobeNewswire - Thu Jul 31, 5:59AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss quarterly results for its second quarter 2014 and provide a general business update on Thursday, August 7, 2014 at 4:30pm ET.
Ekso Bionics(TM) Named 'Leading Robotics Company' by Healthcare Robotics: 2014
GlobeNewswire - Thu Jul 24, 6:01AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was featured in Robotics Business Review Industry Special Report 'Healthcare Robotics: 2014' that describes medical robotic exoskeletons as "probably the most exciting segment of the entire medical robotics market right now."
Kessler Foundation Presents Data on Ekso(TM) at World Congress of Biomechanics
GlobeNewswire - Tue Jul 22, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Kessler Foundation, a global leader in rehabilitation research, has presented preliminary data at World Congress of Biomechanics held in Boston, MA, July 5-10, showing that spinal cord injury (SCI) motor incomplete and complete users were able to actively increase step swing time, stride length and hip extension after walking with an Ekso(TM) robotic exoskeleton. Most notably, muscle activation per gait cycle increased with training and became more similar to able-bodied walking.
Ekso Bionics(TM) Completes Training at Switzerland's Largest Rehabilitation Center
Thomson Reuters ONE - Tue Jul 15, 6:00AM CDT
RICHMOND, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that SPC Nottwil has finished training their team of physiotherapists with their Ekso GT(TM) robotic exoskeleton for neurorehabilitation and started to book patients to learn how to walk again. SPC Nottwil is the largest of Switzerland's four special clinics for para and tetraplegics; they consistently treat over 70% of all people with spinal paralysis in Switzerland and are fully occupied all year round. They have joined an esteemed group of European centers with an Ekso(TM) robotic exoskeleton including the top rated Insitut Guttman in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark, now part of Glostrup Hospital. Robotic exoskeletons have been gaining adoption in the neurorehabilitation community as a strong and growing body of evidence shows they are able to engage the principles of neuroplasticity for improved patient outcomes.
Emerging Market Companies and Investor Updates Provided by BrokerBank Securities, Inc.
PR Newswire - Thu Jun 26, 6:00AM CDT
NYBD Holding, Inc. (OTCBB: NYBD) has filed for a name change and it has been accepted. The company will now be trading under (AQUA), will be named Pleasant Kids, Inc. and the company is expecting the name and symbol change to take affect within the next few business days.
Ekso Bionics(TM) to Present at the 9th Annual JMP Securities Healthcare Conference
GlobeNewswire - Wed Jun 18, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder will present a corporate update at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 2:30 p.m. EDT in New York City. A live demonstration of their bionic exoskeleton technology will also be provided.
Ekso Bionics(TM) CEO Nathan Harding Interviewed Live Today on Fox Business Network's "Opening Bell with Maria Bartiromo"
GlobeNewswire - Fri Jun 13, 5:30AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Maria Bartiromo on Fox Business Network's Opening Bell with Maria Bartiromo. Any interested parties may tune in and listen live.
Ekso Bionics(TM) Announces Launch of Ekso(TM) Labs
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that co-founder Russ Angold was named president of the company's division focused on technology development and future applications, formally named Ekso Labs. Russ will oversee and build out the division that is responsible for developing intellectual property through engineering contracts and research grants from government organizations and industrial partners, including the Department of Defense (DOD). Ekso Bionics has a long history of engineering services work creating an important intellectual property portfolio dating back to the company's inception in 2005.
Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Wed Mar 26, 7:45AM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
